Doernbecher Children's Hospital is an academic teaching children's hospital associated with Oregon Health & Science University located in Portland, Oregon. Established in 1926, it is the first full-service children's hospital in the Pacific Northwest, and provides full-spectrum pediatric care.

During the past decade, Doernbecher Children's Hospital conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 13 clinical trials were completed, i.e. on average, 52% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 6 clinical trials were completed. i.e. 54.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Doernbecher Children's Hospital" #1 sponsor was "Children's Oncology Group" with 38 trials, followed by "National Cancer Institute (NCI)" with 6 trials sponsored, "Oregon Health and Science University" with 5 trials sponsored, "Center for International Blood and Marrow Transplant Research" with 3 trials sponsored and "University of Pennsylvania" with 3 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Doernbecher Children's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 38 trials as a collaborator, "Children's Cancer Group" with 3 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "National Institutes of Health (NIH)" with 3 trials as a collaborator and "National Marrow Donor Program" with 3 trials as a collaborator. Other collaborators include 69 different institutions and companies that were collaborators in the rest 68 trials.

According to Clinical.Site data, the most researched conditions in "Doernbecher Children's Hospital" are "Leukemia" (17 trials), "Sarcoma" (9 trials), "Brain and Central Nervous System Tumors" (6 trials), "Lymphoma" (6 trials) and "Neuroblastoma" (6 trials). Many other conditions were trialed in "Doernbecher Children's Hospital" in a lesser frequency.

Most popular intervention types in "Doernbecher Children's Hospital" are "Drug" (59 trials), "Biological" (23 trials), "Radiation" (23 trials), "Procedure" (18 trials) and "Other" (11 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (19 trials), "filgrastim" (18 trials), "vincristine sulfate" (18 trials), "doxorubicin hydrochloride" (15 trials) and "etoposide" (14 trials). Other intervention names were less common.

The vast majority of trials in "Doernbecher Children's Hospital" are 86 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Doernbecher Children's Hospital". undefined are not yet recruiting, 13 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in Doernbecher Children's Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Doernbecher Children's Hospital, 11 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".